Multaq (dronedarone) is a prescription drug used to reduce the risk of hospitalization in certain adults with atrial fibrillation (AFib). Multaq can cause side effects that range from mild to serious.

Multaq (dronedarone) is a prescription drug used to help reduce the risk of a hospital stay for adults with a history of atrial fibrillation (AFib). The drug comes as an oral tablet that’s usually ...

A trial of the drug Multaq, used to treat abnormal heart rhythm, has been halted over concerns of other heart-related side effects, drug maker Sanofi announced Thursday. Multaq, also known as ...

Multaq (dronedarone) is a brand-name oral tablet prescribed to help reduce the risk of hospitalization for AFib in certain adults. The cost of the drug with and without insurance can depend on several ...

Multaq(R) Approved to Reduce the Risk of Cardiovascular Hospitalizationin Patients With Atrial Fibrillation or Atrial Flutter. PARIS, July 2 /PRNewswire/ -- - U.S Commercial Launch Planned for the ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended new restriction on dronedarone (Multaq), Sanofi's embattled and controversial antiarrhythmic drug.

The PALLAS trial of dronedarone (Multaq) for permanent AF has been stopped early, according to a press release (below) issued by Sanofi. PALLAS (Permanent Atrial fibriLLAtion outcome Study using ...

- Benefit-risk of Multaq remains unchanged in non-permanent AF patients - Paris, France - July 7, 2011 - Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the company has discontinued the ...

The heart drug Multaq continues to be approved for use in Canada, but Health Canada says reports of its connection to liver damage will be reviewed. On Friday, the U.S. Food and Drug Administration ...

PARIS, Nov 16 (Reuters) - Sanofi's irregular heart beat drug Multaq will no longer be reimbursed by the French health system from December, in a further setback to a medicine once seen as a ...

Before Sanofi-Aventis launched its heart drug Multaq, some analysts estimated revenues would top €3 billion. But 10 weeks into the launch, Multaq looks like a much more modest affair, according to a ...

Multaq (dronedarone) is a brand-name oral tablet prescribed to lower the risk of hospitalization for atrial fibrillation in certain adults. As with other drugs, Multaq can cause side effects that ...